NanoViricides
NNVC
#10092
Rank
S$48.06 M
Marketcap
S$2.23
Share price
1.16%
Change (1 day)
36.23%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: S$48.06 Million

As of May 2026 NanoViricides has a market cap of S$48.06 Million. This makes NanoViricides the world's 10092th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$48.06 M45.85%
2025S$32.95 M12.65%
2024S$29.25 M84.87%
2023S$15.82 M-8.41%
2022S$17.27 M-70.19%
2021S$57.96 M43.14%
2020S$40.49 M209.16%
2019S$13.09 M-31.03%
2018S$18.98 M-74.53%
2017S$74.55 M-17.29%
2016S$90.13 M-6.61%
2015S$96.51 M-52.52%
2014S$0.20 B-33.2%
2013S$0.30 B232.6%
2012S$91.5 M-22.44%
2011S$0.11 B-55.11%
2010S$0.26 B66.96%
2009S$0.15 B10.74%
2008S$0.14 B112.56%
2007S$66.86 M

End of Day market cap according to different sources

On May 14th, 2026 the market cap of NanoViricides was reported to be:

S$47.51 Million
by Nasdaq info icon info icon
S$48.06 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
S$209.72 B 436,255.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$358.28 B 745,343.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$148.28 B 308,422.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$130.85 B 272,160.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
S$1.96 B 3,991.77%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$3.11 B 6,373.23%๐Ÿ‡บ๐Ÿ‡ธ USA